Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Researchers at Indiana University School of Medicine have developed a blood test for stress. This test assesses a person's risk of stress,...
Read Full NewsThe Ebola outbreak in Congo has not yet stabilised and is still expanding as population movement fuels transmission, a World Health Organization official said on...
New data show that patients need not exercise intensely to improve outcomes.
In people living with HIV, prescription opioids alone are not linked to worse cognition or mood, but when combined with some drugs, notably antidepressants, they are associated with poorer cognition.
Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.
Patients may not know it, but obesity can lead to more headaches.
The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
Fathers’ adverse childhood experiences are linked to a higher likelihood of their children having behavior problems.
1.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
2.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
3.
'Personalized' Approach to RT for Bladder Cancer Promising but Challenging
4.
Obesity-associated cancers tripled nationwide over past two decades
5.
Breast density changes over time are associated with an increased risk of cancer.
1.
Contemporary Advances in Hematology in the Digital Era
2.
Modern Perspectives in Hematology for Modern Medicine
3.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge